Axsome Therapeutics Depreciation & Amortization 2011-2026 | AXSM

Annual Depreciation & Amortization Axsome Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
503 K	532 K	459 K	263 K	76 K	23.9 K	37.3 K	48.9 K	42.6 K	20.5 K	3.54 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
532 K	3.54 K	183 K

Quarterly Depreciation & Amortization Axsome Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.61 M	1.59 M	149 K	-	1.61 M	1.59 M	132 K	-	1.61 M	1.59 M	90 K	-	1.61 M	926 K	36.6 K	-	45.3 K	18.1 K	8.33 K	-	16.5 K	11 K	5.44 K	-	31.9 K	22.5 K	11.4 K	-	36.7 K	23.7 K	11.9 K	-	31.3 K	20.5 K	10.1 K	-	10.7 K	5.12 K	2.11 K	-	2.29 K	1.17 K	304	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.61 M	304	390 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Axcella Health AXLA	412 K	-	-16.42 %	$ 249 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
CASI Pharmaceuticals CASI	468 K	-	-	$ 35.4 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Chimerix CMRX	91 K	-	-	$ 756 M	USA
AbbVie ABBV	762 M	$ 208.7	-0.07 %	$ 369 B	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	95 K	-	-3.03 %	$ 260 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.52	-0.14 %	$ 1.05 B	Canada